Lithium doesn’t cause a classic withdrawal syndrome the way benzodiazepines or opioids do. Stopping lithium won’t produce a predictable set of physical withdrawal symptoms that follow a neat timeline. What it does cause, and what most people actually experience, is a significant risk of mood episode relapse, particularly mania, that peaks in the first few months after stopping. Understanding the difference between true withdrawal, rebound mood episodes, and the body readjusting to life without lithium is essential for anyone considering discontinuation.
Lithium Withdrawal vs. Mood Relapse
The question of whether lithium produces genuine withdrawal symptoms remains debated in psychiatry. Some people report heightened anxiety, irritability, and sleep disturbances after stopping, but researchers have struggled to confirm whether these are true discontinuation effects or early signs of a returning mood episode. One early study on abrupt lithium discontinuation found no withdrawal symptoms at all. In fact, side effects like hand tremor, excessive urination, muscle weakness, and dry mouth actually improved once lithium was stopped.
What is well documented is the rebound effect on mood stability. Stopping lithium, especially stopping it quickly, can trigger manic or depressive episodes that are more severe and arrive faster than the natural course of the underlying illness would predict. This rebound effect is the real danger of discontinuation and the reason tapering matters so much.
When Relapse Risk Is Highest
The numbers here are striking. In a controlled study of patients with good long-term responses to lithium, 32% experienced a mood episode recurrence within the first month of stopping. By three months, 40% had relapsed. By seven months, 46%. And within the first year, 62% had a new episode. Over a longer follow-up period of up to nine years, 81% of patients eventually relapsed.
Mania tends to return much faster than depression. Analysis of 124 cases found that the time to 25% recurrence of mania was about 2.7 months, compared to 14 months for depression. That means the window right after stopping lithium is disproportionately dangerous for manic episodes. More than half of all new illness episodes occurred within 10 weeks of stopping treatment.
There’s also a concerning finding about suicide risk: one large analysis found a 33% increase in suicidal behavior within 30 days of lithium discontinuation.
Why Stopping Quickly Is Riskier
How fast you stop lithium dramatically changes your risk. People who discontinued lithium rapidly (within two weeks) had a five-year relapse risk nearly three times higher than those who tapered gradually over two to four weeks. In the first 12 months specifically, the risk was 5.4 times greater with rapid discontinuation. This isn’t just about comfort. Abrupt or fast discontinuation can trigger rebound manic and depressive episodes that might not have occurred on the same timeline if the medication had been reduced slowly.
Current clinical guidance recommends tapering lithium over at least three months to minimize relapse risk. This is considerably longer than the two-to-four-week gradual taper used in older studies, reflecting a growing recognition that slower is better.
Physical Changes After Stopping
While lithium may not cause traditional withdrawal symptoms, your body does go through real physical adjustments after discontinuation. Two of the most common long-term side effects of lithium, thyroid suppression and kidney strain, can partially reverse once the drug is stopped.
For thyroid function specifically, recovery is common but not instant. In a retrospective study, about 41% of patients who had developed lithium-related hypothyroidism were eventually able to stop thyroid replacement medication after discontinuing lithium. Of those, about a third stopped thyroid medication within three months, and 71% stopped within one year. The median time to thyroid recovery was roughly six months, though some patients took over three years. Monitoring thyroid levels for three to six months after stopping lithium is a reasonable approach to see if your thyroid rebounds on its own.
Side effects that are directly caused by lithium, like hand tremor, increased thirst, frequent urination, and dry mouth, typically improve relatively quickly once the drug clears your system. Lithium has a half-life of about 18 to 36 hours, so it’s mostly gone from your blood within a few days, though the brain and body may take longer to fully adjust.
What the Adjustment Period Looks Like
If you’re tapering lithium under medical supervision over three months or longer, the adjustment is gradual by design. During and after the taper, the most important things to watch for are changes in sleep, energy levels, and mood. A sudden decrease in your need for sleep, racing thoughts, or an unusual surge of energy and confidence can be early signs of mania returning. On the other end, persistent low mood, loss of interest, or changes in appetite could signal a depressive episode.
The highest-risk period extends from the point you stop (or significantly reduce) your dose through roughly the first six to twelve months. That first seven-month window accounts for nearly half of all relapses in the research. After the first year, the risk doesn’t disappear, but it does slow down considerably. The remaining relapses in long-term studies were spread across years rather than concentrated in months.
For people who have been stable on lithium for a long time, stopping can feel deceptively smooth at first. Many relapses don’t happen in the first week. Only about 7% of patients in the controlled study relapsed that quickly. The more common pattern is a gradual destabilization over weeks to months, which can be easy to miss if you’re not tracking your mood carefully.
Factors That Affect Your Experience
Several things influence how the post-lithium period unfolds for any individual. How long you’ve been taking lithium matters. People treated for longer periods may have a more entrenched neurological adaptation to the drug. The speed of your taper is the single most controllable risk factor. Your underlying diagnosis also plays a significant role: bipolar I disorder with a history of severe manic episodes carries higher rebound risk than milder mood conditions.
Whether you’re switching to another mood stabilizer or stopping mood-stabilizing treatment entirely makes a major difference too. Transitioning to another medication during the taper can provide a safety net that pure discontinuation doesn’t. The research on relapse rates primarily reflects patients who stopped lithium without substituting another agent, so those numbers represent something close to a worst-case scenario for unprotected discontinuation.